Accurate Clinical Management, LLC.

Houston, Texas 77089

1 studies enrolling now · 12 studies all time

What they study most

Arthritis, Rheumatoid, COVID-19, Lupus Erythematosus, Systemic, Lupus Nephritis, Rhematoid Arthritis, Rheumatoid Arthritis, SARS-CoV-2 Infection, Systemic Lupus Erythematosus

Studies at this site

• An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis — Recruiting now
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis — Completed
• A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 — Completed
• Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis — Completed
• A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products — Completed
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate — Completed
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed